BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16978063)

  • 1. PU.1: An ETS family transcription factor that regulates leukemogenesis besides normal hematopoiesis.
    Gupta P; Gurudutta GU; Verma YK; Kishore V; Gulati S; Sharma RK; Chandra R; Saluja D
    Stem Cells Dev; 2006 Aug; 15(4):609-17. PubMed ID: 16978063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
    DeKoter RP; Kamath MB; Houston IB
    Blood Cells Mol Dis; 2007; 39(3):316-20. PubMed ID: 17629523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
    Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PU.1 in hematopoiesis.
    Fisher RC; Scott EW
    Stem Cells; 1998; 16(1):25-37. PubMed ID: 9474745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
    Atar O; Levi BZ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect.
    Vecchiarelli-Federico LM; Liu T; Yao Y; Gao Y; Li Y; Li YJ; Ben-David Y
    Int J Oncol; 2017 Aug; 51(2):456-466. PubMed ID: 28586009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
    Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
    Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia: a central role for the ETS factor ERG.
    Martens JH
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1413-6. PubMed ID: 21664289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTB, the murine homolog of condensin II subunit CAP-G2, represses transcription and promotes erythroid cell differentiation.
    Xu Y; Leung CG; Lee DC; Kennedy BK; Crispino JD
    Leukemia; 2006 Jul; 20(7):1261-9. PubMed ID: 16673016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia.
    Tang JZ; Carmichael CL; Shi W; Metcalf D; Ng AP; Hyland CD; Jenkins NA; Copeland NG; Howell VM; Zhao ZJ; Smyth GK; Kile BT; Alexander WS
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6091-6. PubMed ID: 23533276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.
    Blair DG; Athanasiou M
    Oncogene; 2000 Dec; 19(55):6472-81. PubMed ID: 11175363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
    Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
    Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.